why novartis� landmark cancer drug approval is great news for bluebird
.
.
plemmons and co-authors disclosed no relevant relationships with industry.
.
"there is an issue that needs to be addressed in terms of the narrative the health trust tried to present and mislead the inquest and cover up what actually happened.
.
.
.